CD&R, Merck GHI, and McKesson Ventures invest in M2GEN
Oncology data and informatics platform M2GEN has secured a significant new investment by Clayton, Dubilier & Rice (CD&R) funds, the Merck Global Health Innovation Fund (Merck GHI), and McKesson Ventures. The financial terms of the transaction have not been disclosed. Merck GHI and McKesson Ventures invested alongside CD&R funds, collectively